FIELD: experimental medicine.
SUBSTANCE: It is necessary to inject Klebsiella pneumoniae culture: NCTC strain at the dosage of 109 microbial bodies/kg body weight 6 d after the creation of immunodeficient state due to subcutaneous injection of 2.5%-hydrocortisone acetate emulsion at the dosage of 0.125 mg/100 g body weight thrice at 2-d-long interval. The present innovation enables to create an adequate model of excessive colonization of small intestine at complete reproduction of pathogenetic mechanisms.
EFFECT: higher efficiency of modeling.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MODELING DESTRUCTIVE CHANGES IN LUNGS OF SMALL LABORATORY ANIMALS | 2004 |
|
RU2289855C2 |
| METHOD FOR SIMULATING INTESTINAL YERSINIOSIS IN EXPERIMENTAL ANIMALS | 2014 |
|
RU2566188C1 |
| METHOD FOR MODELING SEPTIC SHOCK AND POLYORGANIC INSUFFICIENCY IN SMALL LABORATORY ANIMALS | 2003 |
|
RU2261481C2 |
| METHOD FOR SIMULATING TYPHOID ON SMALL LABORATORY ANIMALS WITH ARTIFICIAL IMMUNOSUPPRESSION | 2019 |
|
RU2716753C1 |
| METHOD OF PRODUCING LABORATORY MODEL OF ARTIFICIAL PHLEGMONOUS INFLAMMATION OF SOFT TISSUE IN RATS AGAINST BACKGROUND OF ARTIFICIAL IMMUNOSUPPRESSION | 2014 |
|
RU2581255C1 |
| AGENT FOR EARLY TREATMENT OF PATIENTS WITH RADIATION AND COMBINED RADIATION-THERMIC DAMAGES | 1995 |
|
RU2123344C1 |
| METHOD FOR PREDICTING THE RISK OF INTESTINAL COLONIZATION BY KLEBSIELLA PNEUMONIAE IN PRETERM INFANTS IN THE NEONATAL PERIOD | 2022 |
|
RU2793050C1 |
| IMMUNOGENIC ANTI-INFLAMMATORY COMPOSITIONS | 2011 |
|
RU2722357C2 |
| AGENT FOR TREATING INFLAMMATORY DISEASES OF THE JOINTS | 2019 |
|
RU2707278C1 |
| ANTIMICROBIAL IMMUNOMODULATION | 2015 |
|
RU2724895C2 |
